Access Pharmaceuticals-Tom Allinder interviews Jeff Davis, CEO Regarding Recent Developments on MuGard
Great interview right to the point on recent developments with Access Pharma's MuGard...
See our Disclaimer Page

ProActive Capital Indexes
See ProActive's Disclaimer